Skip to Main Content Skip to Site Map Skip to Accessibility Statement Sulfonylureas

Formuary choiceGliclazide tablets 40mg, 80mg

Prescribing Notes

  • Prescribe as per NICE NG28 See also NICE visual summary for blood glucose lowering therapy in adults with type 2 diabetes.
  • Gliclazide modified release tablets should be reserved for patients with demonstrable compliance problems.
  • Patients should be informed that sulfonylureas can cause hypoglycaemia. The risk of hypoglycaemia increases with age.
  • Driving requirements and advice for monitoring of blood glucose in people with type 2 diabetes differ depending on medication and license group. Information may be accessed on the GOV.UK website.
  • Counsel patients on ‘sick day rules’ with sulfonylureas.